Rhythm Biosciences Limited (ASX:RHY)
Australia flag Australia · Delayed Price · Currency is AUD
0.0880
-0.0030 (-3.30%)
Sep 2, 2025, 12:46 PM AEST

Rhythm Biosciences Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212017 - 2020
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2017 - 2020
Net Income
-3.83-6.86-8.22-8.79-6.61
Upgrade
Depreciation & Amortization
0.20.20.190.10.15
Upgrade
Stock-Based Compensation
0.35-1.0532.610.56
Upgrade
Other Operating Activities
-0----
Upgrade
Change in Accounts Receivable
0.38-1.030.91-0.48-0.04
Upgrade
Change in Inventory
0.012.77-2.77--
Upgrade
Change in Accounts Payable
----0.51
Upgrade
Change in Other Net Operating Assets
-0.04-0.16-0.080.070.04
Upgrade
Operating Cash Flow
-2.92-6.14-6.96-6.5-5.4
Upgrade
Capital Expenditures
-0.02-0.08-0.1-0.03-0.07
Upgrade
Cash Acquisitions
-0.52----
Upgrade
Other Investing Activities
-0.04----
Upgrade
Investing Cash Flow
-0.58-0.08-0.1-0.03-0.07
Upgrade
Long-Term Debt Issued
2.15----
Upgrade
Long-Term Debt Repaid
-1.24-0.09-0.09-0.01-0.04
Upgrade
Net Debt Issued (Repaid)
0.91-0.09-0.09-0.01-0.04
Upgrade
Issuance of Common Stock
3.53.023.7412.326.17
Upgrade
Other Financing Activities
-0.22-0.12-0.02-0.47-0.23
Upgrade
Financing Cash Flow
4.192.83.6311.855.9
Upgrade
Net Cash Flow
0.69-3.41-3.435.320.43
Upgrade
Free Cash Flow
-2.94-6.22-7.06-6.52-5.47
Upgrade
Free Cash Flow Margin
-88.52%-367.98%-227.94%-268.74%-493.52%
Upgrade
Free Cash Flow Per Share
-0.01-0.03-0.03-0.03-0.03
Upgrade
Cash Interest Paid
-00.01-0
Upgrade
Cash Income Tax Paid
--1.69-3.08-2.41-1.11
Upgrade
Levered Free Cash Flow
-1.74-3.63-4.12-3.28-2.97
Upgrade
Unlevered Free Cash Flow
-1.7-3.63-4.12-3.28-2.97
Upgrade
Change in Working Capital
0.361.57-1.93-0.410.5
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.